Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature

References

• Jaffe HS, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press 2001 ; International Agency for Research on Cancer, Lyon, France.
   Google Scholar
• De Pas T, Spitaleri G, Pruneri G, Curigliano G, Noberasco C, Luini A, Andreoni B, Testori A, de Braud F. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. Crit Rev Oncol/Hematol 2008; 65:1-7; PMID:17658269; http://dx.doi.org/10.1016/j.critrevonc.2007.06.003
   PubMed Web of Science ®Google Scholar
• Jayaram G, Mun KS, Elsayed EM, Sangkar JV. Interdigitating dendritic reticulum cell sarcoma: cytologic, histologic and immunocytochemical features. Diagn Cytopathol 2005; 33:43-8; PMID:15945093; http://dx.doi.org/10.1002/dc.20275
   PubMed Web of Science ®Google Scholar
• Weiss LM, Beckstead JH, Warnke RA, Wood GS. Leu-6-expressing cells in lymph nodes: dendritic cells phenotypically similar to interdigitating cells. Hum Pathol 1986; 17:179-84; PMID:3081423; http://dx.doi.org/10.1016/S0046-8177(86)80291-X
   PubMed Web of Science ®Google Scholar
• Kairouz S, Hashash J, Kabbara W, McHayleh W, Tabbara IA. Dendritic cell neoplasms: an overview. Am J Hematol 2007; 82:924-8; PMID:17636477; http://dx.doi.org/10.1002/ajh.20857
   PubMed Web of Science ®Google Scholar
• Gaertner EM, Tsokos M, Derringer GA, Neuhauser TS, Arciero C, Andriko JA. Interdigitating dendritic cell sarcoma. A report of four cases and review of the literature. Am J Clin Pathol 2001; 115:589-97; PMID:11293908; http://dx.doi.org/10.1309/M95G-7DQ2-TLQL-7Q11
   PubMed Web of Science ®Google Scholar
• Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-54; PMID:12068308; http://dx.doi.org/10.1038/nature00766
   PubMed Web of Science ®Google Scholar
• Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New Engl J Med 2011; 364:2507-16; PMID:21639808; http://dx.doi.org/10.1056/NEJMoa1103782
   PubMed Web of Science ®Google Scholar
• Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 2010; 116:1919-23; PMID:20519626; http://dx.doi.org/10.1182/blood-2010-04-279083
   PubMed Web of Science ®Google Scholar
• Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, Kim HJ, Park G, Min S, Kim JE. Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology 2014; 65:261-72; PMID:24720374; http://dx.doi.org/10.1111/his.12416
   PubMed Web of Science ®Google Scholar
• Perez-Ordonez B, Rosai J. Follicular dendritic cell tumor: review of the entity. Semin Diag Pathol 1998; 15:144-54; PMID:9606805
   PubMed Web of Science ®Google Scholar
• Saygin C, Uzunaslan D, Ozguroglu M, Senocak M, Tuzuner N. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Crit Rev Oncol/Hematol 2013; 88:253-71; PMID:23755890; http://dx.doi.org/10.1016/j.critrevonc.2013.05.006
   PubMed Web of Science ®Google Scholar
• Schriever F, Freedman AS, Freeman G, Messner E, Lee G, Daley J, Nadler LM. Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 1989; 169:2043-58; PMID:2471772; http://dx.doi.org/10.1084/jem.169.6.2043
   PubMed Web of Science ®Google Scholar
• Sellheyer K, Schwarting R, Stein H. Isolation and antigenic profile of follicular dendritic cells. Clin Exp Immunol 1989; 78:431-6; PMID:2692887
   PubMed Web of Science ®Google Scholar
• Rosenzwajg M, Canque B, Gluckman JC. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 1996; 87:535-44; PMID:8555475
   PubMed Web of Science ®Google Scholar
• Tew JG, Thorbecke GJ, Steinman RM. Dendritic cells in the immune response: characteristics and recommended nomenclature (A report from the Reticuloendothelial Society Committee on Nomenclature). J Reticuloendoth Soc 1982; 31:371-80; PMID:6750114
   PubMedGoogle Scholar
• Steinman RM. Dendritic cells and immune-based therapies. Exp Hematol 1996; 24:859-62; PMID:8690042
   PubMed Web of Science ®Google Scholar
• Uluoglu O, Akyurek N, Uner A, Coskun U, Ozdemir A, Gokcora N. Interdigitating dendritic cell tumor with breast and cervical lymph-node involvement: a case report and review of the literature. Virchows Archiv: Int J Pathol 2005; 446:546-54; PMID:15806378; http://dx.doi.org/10.1007/s00428-005-1209-3
   PubMed Web of Science ®Google Scholar
• Feltkamp CA, van Heerde P, Feltkamp-Vroom TM, Koudstaal J. A malignant tumor arising from interdigitating cells; light microscopical, ultrastructural, immuno-and enzyme-histochemical characteristics. Virchows Archiv A, Pathological Anat Histol 1981; 393:183-92; PMID:6270876; http://dx.doi.org/10.1007/BF00431075
   PubMed Web of Science ®Google Scholar
• Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera RD, Delsol G, De Wolf-Peeters C, Falini B, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41:1-29; PMID:12121233; http://dx.doi.org/10.1046/j.1365-2559.2002.01418.x
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. IARC Press 2008 ; International Agency for Research on Cancer, Lyon, France; 380-428.
   Google Scholar
• Wood GS, Turner RR, Shiurba RA, Eng L, Warnke RA. Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. Am J Pathol 1985; 119:73-82; PMID:3985124
   PubMed Web of Science ®Google Scholar
• Muller-Hermelink HK. Characterization of the B-cell and T-cell regions of human lymphatic tissue through enzyme histochemical demonstration of ATPase and 5′-nucleotidase activities. Virchows Archiv B: Cell Pathol 1974; 16:371-8; PMID:4281966
   PubMedGoogle Scholar
• Fraser CR, Wang W, Gomez M, Zhang T, Mathew S, Furman RR, Knowles DM, Orazi A, Tam W. Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone. Am J Clin Pathol 2009; 132:928-39; PMID:19926586; http://dx.doi.org/10.1309/AJCPWQ0I0DGXBMHO
   PubMed Web of Science ®Google Scholar
• Nayer H, Murphy KM, Hawkins AL, Long PP, Gillison M, Borowitz M, Griffin CA. Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma. Leukemia Lymphoma 2006; 47:2651-4; PMID:17169812; http://dx.doi.org/10.1080/10428190600879896
   PubMed Web of Science ®Google Scholar
• Galli F, Petraitiene V, Muthu SK, James S, Koppana VR, Arya A. Challenges in the differential diagnosis of interdigitating dendritic cell sarcoma of intraparotid lymph node vs. metastatic malignant melanoma with unknown primary site. Int J Surg Pathol 2015; 23:248-52; PMID:25722315
   PubMed Web of Science ®Google Scholar
• Amir G, Weintraub M. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis. Pediat Blood Cancer 2008; 50:304-7; PMID:17455317; http://dx.doi.org/10.1002/pbc.21198
   PubMed Web of Science ®Google Scholar
• Orii T, Takeda H, Kawata S, Maeda K, Yamakawa M. Differential immunophenotypic analysis of dendritic cell tumours. J Clin Pathol 2010; 63:497-503; PMID:20439325; http://dx.doi.org/10.1136/jcp.2009.067819
   PubMed Web of Science ®Google Scholar
• Dorfman DM, Hornick JL, Shahsafaei A, Freeman GJ. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms. Hum Pathol 2010; 41:1486-94; PMID:20656318; http://dx.doi.org/10.1016/j.humpath.2010.04.005
   PubMed Web of Science ®Google Scholar
• Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997; 79:294-313; PMID:9010103; http://dx.doi.org/10.1002/(SICI)1097-0142(19970115)79:2%3c294::AID-CNCR13%3e3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Chan AC, Chan KW, Chan JK, Au WY, Ho WK, Ng WM. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology 2001; 38:510-8; PMID:11422494; http://dx.doi.org/10.1046/j.1365-2559.2001.01134.x
   PubMed Web of Science ®Google Scholar
• Galati LT, Barnes EL, Myers EN. Dendritic cell sarcoma of the thyroid. Head Neck 1999; 21:273-5; PMID:10208672; http://dx.doi.org/10.1002/(SICI)1097-0347(199905)21:3%3c273::AID-HED14%3e3.0.CO;2-Q
   PubMed Web of Science ®Google Scholar
• Fonseca R, Yamakawa M, Nakamura S, van Heerde P, Miettinen M, Shek TW, Myhre Jensen O, Rousselet MC, Tefferi A. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol 1998; 59:161-7; PMID:9766802; http://dx.doi.org/10.1002/(SICI)1096-8652(199810)59:2%3c161::AID-AJH10%3e3.0.CO;2-C
   PubMed Web of Science ®Google Scholar
• Weiss LM, Berry GJ, Dorfman RF, Banks P, Kaiserling E, Curtis J, Rosai J, Warnke RA. Spindle cell neoplasms of lymph nodes of probable reticulum cell lineage. True reticulum cell sarcoma? Am J Surg Path 1990; 14:405-14; PMID:2158241; http://dx.doi.org/10.1097/00000478-199005000-00001
   PubMed Web of Science ®Google Scholar
• Rousselet MC, Francois S, Croue A, Maigre M, Saint-Andre JP, Ifrah N. A lymph node interdigitating reticulum cell sarcoma. Arch Pathol Lab Med 1994; 118:183-8; PMID:8311662
   PubMed Web of Science ®Google Scholar
• Salisbury JR, Ramsay AD, Isaacson PG. Histiocytic lymphoma: a report of a case with an unusual phenotype. J Pathol 1985; 146:99-106; PMID:3891942; http://dx.doi.org/10.1002/path.1711460204
   PubMed Web of Science ®Google Scholar
• Olnes MJ, Nicol T, Duncan M, Bohlman M, Erlich R. Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy. Leukemia Lymphoma 2002; 43:817-21; PMID:12153170; http://dx.doi.org/10.1080/10428190290016944
   PubMed Web of Science ®Google Scholar
• Kawachi K, Nakatani Y, Inayama Y, Kawano N, Toda N, Misugi K. Interdigitating dendritic cell sarcoma of the spleen: report of a case with a review of the literature. Am J Surg Pathol 2002; 26:530-7; PMID:11914634; http://dx.doi.org/10.1097/00000478-200204000-00018
   PubMed Web of Science ®Google Scholar
• Satoh T, Smith A, Sarde A, Lu HC, Mian S, Trouillet C, Mufti G, Emile JF, Fraternali F, Donadieu J, et al. B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PloS One 2012; 7:e33891; PMID:22506009; http://dx.doi.org/10.1371/journal.pone.0033891
   PubMed Web of Science ®Google Scholar
• Sahm F, Capper D, Preusser M, Meyer J, Stenzinger A, Lasitschka F, Berghoff AS, Habel A, Schneider M, Kulozik A, et al. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood 2012; 120:e28-34; PMID:22859608; http://dx.doi.org/10.1182/blood-2012-06-429597
   PubMed Web of Science ®Google Scholar
• O'Malley DP, Agrawal R, Grimm KE, Hummel J, Glazyrin A, Dim DC, Madhusudhana S, Weiss LM. Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. Ann Diag Pathol 2015; 19:113-6; PMID:25787243; http://dx.doi.org/10.1016/j.anndiagpath.2015.02.008
   PubMed Web of Science ®Google Scholar
• Ahmadzadeh A, Shahrabi S, Jaseb K, Norozi F, Shahjahani M, Vosoughi T, Hajizamani S, Saki N. BRAF mutation in hairy cell leukemia. Oncol Rev 2014; 8:253; PMID:25992240; http://dx.doi.org/10.4081/oncol.2014.253
   PubMedGoogle Scholar
• Vergote V, Dierickx D, Janssens A, Verhoef G, Tousseyn T, Vandenberghe P, Wolter P, Delforge M. Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib. Ann Hematol 2014; 93:2087-9; PMID:24863690; http://dx.doi.org/10.1007/s00277-014-2104-2
   PubMed Web of Science ®Google Scholar
• Bailleux C, Robert G, Ginet C, Re D, Thyss A, Sudaka I, Peyrottes I, Hofman P, Auberger P, Peyrade F. Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib. Oncoscience 2015; 2:44-9; PMID:25815361
   PubMedGoogle Scholar
• Haroche J, Charlotte F, Arnaud L, von Deimling A, Helias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 2012; 120:2700-3; PMID:22879539; http://dx.doi.org/10.1182/blood-2012-05-430140
   PubMed Web of Science ®Google Scholar